Home › Upcoming votes › Traws Pharma, Inc.
The deadline as the proxy statement states it: “Vote by 11:59 P.M. Eastern Time on December 2, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Traws Pharma, Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | APPROVAL OF REVERSE STOCK SPLIT AUTHORIZATION | Board | For | — |
| 2 | APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING TO SOLICIT ADDITIONAL VOTES Adjournment |
Board | For | — |
From Traws Pharma, Inc.’s Form 8-K, filed November 28, 2025, for the meeting held November 21, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Iain Dukes, D.Phil. | 98% | Elected |
| Elect Director: Werner Cautreels, Ph.D. | 98% | Elected |
| Elect Director: Trafford Clarke, Ph.D. | 98% | Elected |
| Elect Director: John Leaman, M.D. | 98% | Elected |
| Elect Director: Nikolay Savchuck Ph.D. | 98% | Elected |
| Elect Director: M. Teresa Shoemaker | 98% | Elected |
| Elect Director: Jack E. Stover | 98% | Elected |
| 2. To consider and vote upon the amendment and restatement of the Company's 2021 Incentive Compensation Plan, as amended and restated | 90% | Approved |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers | 96% | Approved |
| 5. To consider and vote upon the ratification of the selection of KPMG LLP as the Company's independent registered public accounting firm fo | 99% | Approved |
| 6. To approve the adjournment of the Annual Meeting to another place, or a later date or dates, if necessary or appropriate, to solicit addi | 92% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.